TTM
$3.52B
YoY change
+0.3%
5Y CAGR
+10.8%
Peak year (2025)
$3.46B
Cumulative EBITDA
$28.52B
EBITDA history chart for IQVIA (IQV) from 2010 to 2025
Latest: $3.46B
EBITDA growth chart for IQVIA (IQV) from 2010 to 2025
Latest: +0.3%
EBITDA history table for IQVIA (IQV) from 2010 to 2025
| 2025 | $3.46B | +0.3% | +$11.00M | ||
| 2024 | $3.45B | +6.1% | +$197.00M | ||
| 2023 | $3.26B | +11.9% | +$347.00M | ||
| 2022 | $2.91B | +5.1% | +$142.00M | ||
| 2021 | $2.77B | +33.3% | +$691.00M | ||
| 2020 | $2.08B | +3.7% | +$75.00M | ||
| 2019 | $2.00B | +6.3% | +$118.00M | ||
| 2018 | $1.88B | +14.1% | +$232.00M | ||
| 2017 | $1.65B | +94.5% | +$802.00M | ||
| 2016 | $849.00M | +10.5% | +$81.00M | ||
| 2015 | $768.00M | +6.2% | +$45.00M | ||
| 2014 | $723.00M | +30.5% | +$168.87M | ||
| 2013 | $554.13M | +10.8% | +$54.04M | ||
| 2012 | $500.09M | +29.6% | +$114.34M | ||
| 2011 | $385.74M | -17.5% | −$81.63M | ||
| 2010 | $467.37M | — | — |
- 2025$3.46B+0.3%
- 2024$3.45B+6.1%
- 2023$3.26B+11.9%
- 2022$2.91B+5.1%
- 2021$2.77B+33.3%
- 2020$2.08B+3.7%
- 2019$2.00B+6.3%
- 2018$1.88B+14.1%
- 2017$1.65B+94.5%
- 2016$849.00M+10.5%
- 2015$768.00M+6.2%
- 2014$723.00M+30.5%
- 2013$554.13M+10.8%
- 2012$500.09M+29.6%
- 2011$385.74M-17.5%
- 2010$467.37M—
EBITDA values are taken from IQVIA's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at IQVIA (IQV)
According to IQVIA's latest reported financial statements, the company's current EBITDA (TTM) is $3.52B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual EBITDA for IQVIA (IQV) came in at $3.46B – edged up 0.3% year-over-year.
IQVIA EBITDA compound annual growth for the 2020–2025 (5 years) window is +10.8%, sustaining 14 straight years of year-over-year growth.
The record annual EBITDA stands at $3.46B, reached in 2025; the historical low of $385.74M was recorded in 2011.
IQVIA EBITDA by Year
IQVIA EBITDA 2025: $3.46B
IQVIA EBITDA in 2025 was $3.46B, edged up 0.3% from 2024. This figure represents the highest annual value in the available history.
IQVIA EBITDA 2024: $3.45B
2024's EBITDA for IQVIA came in at $3.45B, grew 6.1% from 2023.
IQVIA EBITDA 2023: $3.26B
IQVIA posted EBITDA of $3.26B in 2023, grew 11.9% from 2022.
IQVIA EBITDA 2022: $2.91B
In 2022, IQVIA reported EBITDA of $2.91B, grew 5.1% from 2021.
IQVIA EBITDA 2021: $2.77B
IQVIA EBITDA in 2021 was $2.77B.
See more financial history for IQVIA (IQV).
Sector peers by EBITDA
Healthcare peers of IQVIA (IQV), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
IQVIA (IQV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation